Contents

Current Bioactive Compounds, Volume 7 - Number 1

Editorial [Hot Topic: Anticancer Macromolecular Prodrugs in Clinical Trials - an Update (Guest Editor: Felix Kratz)]

, 7(1): 1 - 2

Felix Kratz


DOI: 10.2174/157340711795163857




EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data

, 7(1): 3 - 7

Hong Zhao


DOI: 10.2174/157340711795163802




CRLX101 (formerly IT-101) – A Novel Nanopharmaceutical of Camptothecin in Clinical Development

, 7(1): 8 - 14

Cissy Young, Thomas Schluep, Jungyeon Hwang and Scott Eliasof


DOI: 10.2174/157340711795163866




XMT-1001, A Novel Biodegradable Polyacetal Polymer Conjugate of Camptothecin in Clinical Development

, 7(1): 15 - 20

A. V. Yurkovetskiy and R. J. Fram


DOI: 10.2174/157340711795163839




AP5346 (ProLindac™), A DACH Platinum Polymer Conjugate in Phase II Trials Against Ovarian Cancer

, 7(1): 21 - 26

David P. Nowotnik


DOI: 10.2174/157340711795163794




ONCOFID™-P a Hyaluronic Acid Paclitaxel Conjugate for the Treatment of Refractory Bladder Cancer and Peritoneal Carcinosis

, 7(1): 27 - 32

Monica Campisi and Davide Renier


DOI: 10.2174/157340711795163848




INNO-206 (DOXO-EMCH), an Albumin-Binding Prodrug of Doxorubicin Under Development for Phase II Studies

, 7(1): 33 - 38

F. Kratz


DOI: 10.2174/157340711795163785




A Randomized, Double Blind, Controlled, Dose Dependent Clinical Trial to Evaluate the Efficacy of a Proanthocyanidin Standardized Whole Cranberry (Vaccinium macrocarpon) Powder on Infections of the Urinary Tract

, 7(1): 39 - 46

K. Sengupta, K. V. Alluri, T. Golakoti, G. V. Gottumukkala, J. Raavi, L. Kotchrlakota, S. C. Sigalan, D. Dey, S. Ghosh and A. Chatterjee


DOI: 10.2174/157340711795163820




Chemistry and Biological Activities of Buxus Alkaloids

, 7(1): 47 - 64

Yu-Xin Yan, Yun Sun, Zhong-Rong Li, Lin Zhou and Ming-Hua Qiu


DOI: 10.2174/157340711795163811




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science